Analysts' Actions: Apple, Facebook, Twitter

NEW YORK (TheStreet) -- RATINGS CHANGES

Apple (AAPL) was initiated with a buy rating at Deutsche Bank. Twelve-month price target is $650. Company is positioned well for the next generation of IT, Deutsche Bank said.

AmerisourceBergen (ABC) was upgraded at FBR Capital Markets to outperform. Twelve-month price target is $75. Stock has pulled back 10% over the past three months, FBR Capital Markets said.

Alkermes (ALKS) was upgraded at Mizuho to buy from neutral. Twelve-month price target is $61. Stock is attractive, following recent weakness, Mizuho said.

Cabot (COG) was downgraded at Stifel Nicolaus to hold from buy. Company will likely miss 2014 cash flow expectations, Stifel Nicolaus said. See fair value between $36 and $38, Stifel Nicolaus said.

CF Capital (CF) was downgraded at Barclays to equal-weight from overweight. Valuation call with near-term upside limited, Barclays said. Twelve-month price target is $267.

Dexcom (DXCM) was upgraded at Sterne Agee to buy from neutral. Twelve-month price target is $50. Superior CGM technology will continue to drive strong revenue growth, Sterne Agee said.

El Paso Pipeline Partners (EPB) initiated at UBS with a neutral rating. Recontracting will create some headwinds for the partnership, UBS said. Twelve-month price target is $32.

Facebook (FB) was upgraded at Pivotal Research to hold from buy. Twelve-month price target is $72. Company can generate sustained growth in the future, Pivotal said.

IBM (IBM) was initiated with a hold rating at Deutsche Bank. Twelve-month price target is $200. Virtualization continues to change the spending landscape, Deutsche Bank said.

Imperva (IMPV) was downgraded at Oppenheimer to perform from outperform. Twelve-month price target is $65. Company is seeing increased competition and weakness in the U.S., Oppenheimer said.

Mistras (MG) was downgraded to hold at TheStreet Ratings.

Netflix (NFLX) was upgraded at Hudson Square to buy from hold. Twelve-month price target is $409. Stock has pulled back 23%, but expect a strong seasonal quarter, Hudson Square said.

Palo Alto Networks (PANW) was upgraded at JMP Securities to outperform from market perform. Twelve-month price target is $80. Company is becoming a leader in the APT market, JMP Securities said.

Premier (PINC) was upgraded at ISI Group to buy from neutral. Twelve-month price target is $39.50. Stock has lagged year-to-date, but the company can generate double-digit growth, ISI Group said.

Royal Bank of Scotland (RBS) was downgraded to sell at TheStreet Ratings.

Molson Coors (TAP) was downgraded at Nomura to neutral from buy. Valuation call, based on a 12-month price target of $60, Nomura said.

Twitter (TWTR) was upgraded at Cantor Fitzgerald to hold from sell. Twelve-month price target is $45. See better near-term results, aided by the launch of new ad formats, Cantor Fitzgerald said.

WESCO International (WCC) was upgraded at UBS to buy from neutral. Organic growth likely to reaccelerate as end markets begin to recover, UBS said. M&A is expected to supplement core growth, UBS said. Twelve-month price target is $100.

Wex (WEX) was upgraded at Citigroup to buy. Twelve-month price target is $109. Confidence is growing in the company's accelerated growth profile, Citigroup said.

Stock Comments / EPS Changes

Advance Auto (AAP) was added to the Best Ideas List at Wedbush. Checks show an improving core business and additional revenue synergies, Wedbush said. Twelve-month price target is $150.

Athlon Energy (ATHL) 12-month price target was raised at UBS. Driven by accretive Midland acquisition, UBS said. Twelve-month price target is $42. Neutral rating.

Bed Bath & Beyond (BBBY) numbers were cut at J.P. Morgan. Twelve-month price target is now $75. Estimates were also reduced, given margin pressure, J.P. Morgan said. Neutral rating.

Bed Bath & Beyond 12-month price target was cut at Barclays to $80. Lower-than-expected fourth-quarter numbers and ongoing deterioation of gross margins, Barclays said.

Charles River Laboratories (CRL) 12-month price target was increased to $73 at Jefferies. Earnings estimates were also increased. Outsourced R&D spending is expected to grow with biotech funding contributing, Jefferies said. Buy rating.

Covance (CVD) 12-month price target was raised to $117 at Jefferies. Driven by exposure to biotech and early development, Jefferies said. Buy rating.

Delphi (DLPH) 12-month price target was raised at Barclays to $82. Driven by exposure to secular growth and margin moats, Barclays said.

MSC Industrial Direct (MSM) 12-month price target was increased at UBS to $93. Beat on margins despite weather and improving operating improvement, UBS said. Neutral rating.

Constellation Brands (STZ) numbers were boosted at Societe Generale. Twelve-month price target is now $77. Estimates were also increased, given higher growth in the beer business, Societe Generale said. Sell rating.

Follow TheStreet on Twitter and become a fan on Facebook

This article was written by a staff member of TheStreet.

If you liked this article you might like

There Are Many Signs Investors Have Totally Forgotten About S&P 500 Correction

There Are Many Signs Investors Have Totally Forgotten About S&P 500 Correction

Quick Tips: Now What Should Investors Do?

Quick Tips: Now What Should Investors Do?

7 Inexpensive ETFs for Small-Cap and Micro-Cap Exposure

7 Inexpensive ETFs for Small-Cap and Micro-Cap Exposure

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Shorts Trampled In Bull Market Rally; UPS Share Structure Examined -- ICYMI

Shorts Trampled In Bull Market Rally; UPS Share Structure Examined -- ICYMI